Fundraising Fox
/People
Sign in

PAUL LAMMERS, MD, MSc

Executive at Triumvira Immunologics · Executive at Mirna Therapeutics

Austin, Texas, United States

Find your path to PAUL

86 people in our graph share verified history with PAUL — schools, employers, funds. One of them is your warm intro.

Widya MulyasasmitaunlockedPAUL: together at Triumvira Immunologics (2022–2023)
×2PAUL: together at Salarius Pharmaceuticals
PAUL: together at Triumvira Immunologics
PAUL: together at Mirna Therapeutics, Inc.

Executive at Triumvira Immunologics

Intro paths

→

In turn, PAUL can intro founders to Triumvira Immunologics's investors below.

Triumvira Immunologics's investors · 6

B Capital GroupManhattan Beach · $10M – $50M checks · since 2022B4 Capital$10M – $50M checksCheckmate Capital Group LLCPasadenaLeaps by BayerLeverkusen · since 2020Northpond VenturesBethesda · $100K – $5M checks · since 2020Oceanpine CapitalBeijing · since 2020

Executive at Mirna Therapeutics

Intro paths

→

In turn, PAUL can intro founders to Mirna Therapeutics's investors below.

Mirna Therapeutics's investors · 8

Correlation VenturesSan Francisco · $100K – $4M checksNew Enterprise Associates (NEA)Menlo Park · $200K – $40M checksOrbiMedNew York · $1M – $75M checks · since 2019Osage University PartnersBala CynwydOUP (Osage University Partners)Bala Cynwyd · $1M – $20M checks · since 2012Pfizer Venture Investments$5M – $20M checksPfizer VenturesSofinnova VenturesMenlo Park · $100K – $15M checks

Co-founders at Mirna Therapeutics

MW
Matthew WinklerDirector

Experience

  1. Decoy Therapeutics Inc.Board Director & Chair of Comp Committeecurrent2025 — presentBoston, MA
  2. NUAgo TherapeuticsBoard Membercurrent2024 — present
  3. NUAgo TherapeuticsDirector Board of Directorscurrent2024 — presentNorth America
  4. Salarius PharmaceuticalsMember Board of Directorscurrent2024 — presentHouston, TX
  5. Diakonos OncologyBoard Membercurrent2024 — present
  6. Diakonos OncologyDirector Board of Directorscurrent2024 — presentHouston, TX
  7. ImmunoMet Therapeutics, Inc.Member Board of Directors2019 — 2025United States
  8. ImmunoMet Therapeutics, Inc.Chairman of the Board2024 — 2025
  9. Triumvira ImmunologicsChief Executive Officer2018 — 2024Austin, Texas
  10. Lammers Consulting LLCBiotech Consultant2017 — 2018Austin, Texas Area
  11. Mirna Therapeutics, Inc.President & CEO2009 — 2017
  12. Repros TherapeuticsPresident2009
  13. EMD Serono, Inc.Chief Medical Officer & Head of Global Product Development for the US2002 — 2008
  14. Organon USMedical Director1992 — 1996
  15. Organon InternationalMedical Director1989 — 1992Oss, The Netherlands

Skills & more

BiotechnologyPharmaceutical IndustryClinical DevelopmentDrug DevelopmentOncologyLifesciencesResearchStrategic PlanningBusiness StrategyClinical TrialsLife SciencesProduct Development
+12 moreBiopharmaceuticalsMarketing StrategyMedicineMedical WritingGCPQuality AssurancePowerPointMicrosoft OfficeMicrosoft ExcelMicrosoft WordLeadershipManagement

Languages Dutch · English · German

From PAUL's professional profile.

Frequently asked questions

Who is PAUL LAMMERS, MD, MSc?
Executive Officer, Director at Triumvira Immunologics
Where does PAUL LAMMERS, MD, MSc work?
PAUL LAMMERS, MD, MSc is Executive at Triumvira Immunologics and Executive at Mirna Therapeutics.
Where did PAUL LAMMERS, MD, MSc go to school?
PAUL LAMMERS, MD, MSc studied at Radboud University (Doctor of Medicine (M.D.), Biology/Biological Sciences, General and Medicine); Radboud University (Master of Science (M.Sc.), Reproductive Biology).

Founder mafias

Same school

Shared employers

Also worked at Mirna Therapeutics, Inc.1

JON IRVINExecutive Officer at Triumvira Immunologics